Literature DB >> 30225235

A novel NF1 frame-shift mutation c.703_704delTA in a Chinese pedigree with neurofibromatosis type 1.

Jun Chen1, Bo Guo1, Min Ren2, Hong Lin1, Xin Zhang1, Si-Yi Chen1, Xiao-Tian Yu1, Zhu-Ping Xu1.   

Abstract

We analyzed the clinical features and NF1 gene mutation in a Chinese pedigree of neurofibromatosis type 1 (NF1). Three members of this family were NF1 patients presenting with different clinical phenotypes and the others were asymptomatic. Exons of NF1 were amplified by polymerase chain reaction, sequenced, compared with a reference database. One novel NF1 frame-shift mutation c.703_704delTA, which resulted in a premature stop signal at codon 720 and the synthesis of truncated, was revealed. This mutation segregated with the NF1 members is likely responsible for the pathogenesis of NF1 in the family.

Entities:  

Keywords:  NF1 gene; frame-shift mutation; neurofibromatosis type 1

Year:  2018        PMID: 30225235      PMCID: PMC6133898          DOI: 10.18240/ijo.2018.09.22

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  18 in total

Review 1.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

Review 2.  Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.

Authors:  Anna Abramowicz; Monika Gos
Journal:  Dev Period Med       Date:  2014 Jul-Sep

3.  Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic.

Authors:  K North
Journal:  J Child Neurol       Date:  1993-10       Impact factor: 1.987

4.  NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.

Authors:  Audrey Sabbagh; Eric Pasmant; Apolline Imbard; Armelle Luscan; Magali Soares; Hélène Blanché; Ingrid Laurendeau; Salah Ferkal; Michel Vidaud; Stéphane Pinson; Christine Bellanné-Chantelot; Dominique Vidaud; Béatrice Parfait; Pierre Wolkenstein
Journal:  Hum Mutat       Date:  2013-08-26       Impact factor: 4.878

5.  Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.

Authors:  Yasuko Hirata; Hilde Brems; Mayu Suzuki; Mitsuhiro Kanamori; Masahiro Okada; Rimpei Morita; Isabel Llano-Rivas; Toyoyuki Ose; Ludwine Messiaen; Eric Legius; Akihiko Yoshimura
Journal:  J Biol Chem       Date:  2015-12-03       Impact factor: 5.157

Review 6.  [Neurofibromin - protein structure and cellular functions in the context of neurofibromatosis type I pathogenesis].

Authors:  Anna Abramowicz; Monika Gos
Journal:  Postepy Hig Med Dosw (Online)       Date:  2015-12-09       Impact factor: 0.270

7.  A novel NF1 frame-shift mutation (c.702_703delGT) in a Chinese family with neurofibromatosis type 1.

Authors:  S P Cai; N Fan; J Chen; Z L Xia; Y Wang; X M Zhou; Y Yin; T L Wen; Q J Xia; X Y Liu; H Y Wang
Journal:  Genet Mol Res       Date:  2014-07-24

Review 8.  The NF1 gene revisited - from bench to bedside.

Authors:  Yoon-Sim Yap; John R McPherson; Choon-Kiat Ong; Steven G Rozen; Bin-Tean Teh; Ann S G Lee; David F Callen
Journal:  Oncotarget       Date:  2014-08-15

9.  Clinical and Molecular Characterization of NF1 Patients: Single-Center Experience of 32 Patients From China.

Authors:  Lude Zhu; Yunfeng Zhang; Hanxing Tong; Minhua Shao; Yong Gu; Xufeng Du; Peiru Wang; Lei Shi; Linglin Zhang; Mingye Bi; Xiuli Wang; Guolong Zhang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

10.  Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.

Authors:  Giovanni Corsello; Vincenzo Antona; Gregorio Serra; Federico Zara; Clara Giambrone; Luca Lagalla; Maria Piccione; Ettore Piro
Journal:  Ital J Pediatr       Date:  2018-04-04       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.